Han Dongsheng, editor-in-chief of China Audiology Network, said that it has always been the dream of the Chinese people to develop digital hearing aids with China’s own intellectual property rights. However, the “brains†(ie, algorithms) of such digital hearing aids cannot be purchased but only created.
In the past year, the start-up of the multi-channel cochlear implant made in China and its far lower than the expected sales price of imported cochlear implants have attracted the attention of many potential users. It is understood that the current domestic multi-channel cochlear implant has completed 60 clinical tests. However, people in the industry believe that it may take some time for the artificial cochlea to be truly domesticated and put into the market.
In early 2011, the State Council and the National Development and Reform Commission issued several important policies on opening up the domestic medical market investment. A report released by the US Global Analysis Company predicts that by 2015, the global hearing instrument market will reach 22 billion U.S. dollars. The fastest-growing region is the Asia-Pacific region, where the hearing-impaired people account for more than half of the world, but the use of hearing aids and cochlear implants However, it is extremely low, and the region will maintain a compound growth rate of at least 9%. China, Russia, Brazil, and India will become the main growth countries.
The hearing rehabilitation industry has been closely watched by overseas capital. A few years ago, Switzerland's Fengli Group had amassed two companies that were the domestic distributors of Ulicon and Fengli products at that time and had already set up factories in Suzhou. Subsequently, other hearing aid manufacturers also set up factories in China.
With the rapid development of China's economy, especially hearing recovery products have received government financial subsidies and subsidies. In some regions, hearing aids can be partially or completely reimbursed, so sales will increase dramatically. It is expected that in 2011, foreign hearing aid companies or some equity investors may have capital interventions in hearing aid stores with a certain market share and scale.
In the past year, the start-up of the multi-channel cochlear implant made in China and its far lower than the expected sales price of imported cochlear implants have attracted the attention of many potential users. It is understood that the current domestic multi-channel cochlear implant has completed 60 clinical tests. However, people in the industry believe that it may take some time for the artificial cochlea to be truly domesticated and put into the market.
In early 2011, the State Council and the National Development and Reform Commission issued several important policies on opening up the domestic medical market investment. A report released by the US Global Analysis Company predicts that by 2015, the global hearing instrument market will reach 22 billion U.S. dollars. The fastest-growing region is the Asia-Pacific region, where the hearing-impaired people account for more than half of the world, but the use of hearing aids and cochlear implants However, it is extremely low, and the region will maintain a compound growth rate of at least 9%. China, Russia, Brazil, and India will become the main growth countries.
The hearing rehabilitation industry has been closely watched by overseas capital. A few years ago, Switzerland's Fengli Group had amassed two companies that were the domestic distributors of Ulicon and Fengli products at that time and had already set up factories in Suzhou. Subsequently, other hearing aid manufacturers also set up factories in China.
With the rapid development of China's economy, especially hearing recovery products have received government financial subsidies and subsidies. In some regions, hearing aids can be partially or completely reimbursed, so sales will increase dramatically. It is expected that in 2011, foreign hearing aid companies or some equity investors may have capital interventions in hearing aid stores with a certain market share and scale.
Dongguan City Risen Medical Products Co., Ltd. , https://www.risenppe.com